MBHB Partner Kevin Noonan Authors BioProcess International Article, “The Biosimilars Action Plan: Promoting Faster and More Extensive Adoption of Biosimilar Drugs”
January 11, 2022
McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D., authored a BioProcess International article entitled, “The Biosimilars Action Plan: Promoting Faster and More Extensive Adoption of Biosimilar Drugs.” View the article
